RespireRx Pharmaceuticals Inc (fka RSPI)

[haysaw]

I don't know what 'facts' you are referring to, but this is the 12-month pps movement on PPH:

Last Trade: 64.92
52wk Range: 49.28 - 70.18

..and XPH:

Last Trade: 38.80
52wk Range: 23.60 - 40.89

...and PFE:

Last Trade: 17.69
52wk Range: 11.62 - 20.36

Is this the 'instability' you were suggesting is responsible for Cor not achieving a partnership?


Late development...Now I see it is the PhIIb RD trial design fears that may have kept a partnership away. It only took 17 months to 'design' that excuse. Gfp, Neuro, job well done!

Who'd a thought these pharma leaders would be so driven by fear. Fear trumps greed. Greed trumps truth. Truth trumps.....